Hereditary angioedema type I
Clinical trials for Hereditary angioedema type I explained in plain language.
Never miss a new study
Get alerted when new Hereditary angioedema type I trials appear
Sign up with your email to follow new studies for Hereditary angioedema type I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Recruiting nowThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE I
Phase 4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New hope for kids with rare swelling disorder as drug trial begins
Disease control Recruiting nowThis study tests a drug called donidalorsen in 20 children aged 2 to 12 with hereditary angioedema (HAE), a condition that causes sudden, painful swelling. The goal is to see if the drug is safe and how it works in young bodies. Researchers will monitor side effects and measure h…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE I
Phase 3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to stop swelling attacks in hereditary angioedema
Disease control Recruiting nowThis phase 3 study tests an intravenous C1 esterase inhibitor (C1-INH) in people with hereditary angioedema (HAE) to treat acute attacks and prevent attacks before medical procedures. About 124 participants, aged 2 and older, will receive either the drug or a placebo. The main go…
Matched conditions: HEREDITARY ANGIOEDEMA TYPE I
Phase 3 • Sponsor: Octapharma • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC